WO2002069936A3 - Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions - Google Patents

Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions Download PDF

Info

Publication number
WO2002069936A3
WO2002069936A3 PCT/IB2002/000534 IB0200534W WO02069936A3 WO 2002069936 A3 WO2002069936 A3 WO 2002069936A3 IB 0200534 W IB0200534 W IB 0200534W WO 02069936 A3 WO02069936 A3 WO 02069936A3
Authority
WO
WIPO (PCT)
Prior art keywords
soft gelatin
ibuprofen
active ingredient
gelatin capsule
pharmaceutical composition
Prior art date
Application number
PCT/IB2002/000534
Other languages
English (en)
Other versions
WO2002069936A2 (fr
Inventor
Prashant Manohar Mandaogade
Ujwal Damu Kolhe
Abhijit Mukund Deshmukh
Mailatur Sivaraman Mohan
Original Assignee
Reddys Lab Ltd Dr
Prashant Manohar Mandaogade
Ujwal Damu Kolhe
Abhijit Mukund Deshmukh
Mailatur Sivaraman Mohan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Prashant Manohar Mandaogade, Ujwal Damu Kolhe, Abhijit Mukund Deshmukh, Mailatur Sivaraman Mohan filed Critical Reddys Lab Ltd Dr
Priority to AU2002244865A priority Critical patent/AU2002244865A1/en
Publication of WO2002069936A2 publication Critical patent/WO2002069936A2/fr
Publication of WO2002069936A3 publication Critical patent/WO2002069936A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un principe actif, l'ibuprofène ou (S)(+)-ibuprofène en tant que base libre ou en tant que sels de métal alcalin, ou que de mélanges desdits composants, sous forme d'une capsule en gélatine molle, lesdites capsules en gélatine molle présentant une composition de masse de gel de capsule en gélatine molle permettant de favoriser la solubilisation du principe actif. L'invention concerne également le procédé de production d'une telle capsule en gélatine molle ou d'une telle composition de masse de gel de gélatine molle. Un autre aspect de l'invention permet d'éviter l'utilisation de polyéthylène glycol ou d'espèces d'ions hydroxydes contenant des solvants en tant que solubilisateurs, pour la préparation de capsules en gélatine molle contenant ledit principe actif.
PCT/IB2002/000534 2001-03-02 2002-02-22 Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions WO2002069936A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002244865A AU2002244865A1 (en) 2001-03-02 2002-02-22 Pharmaceutical composition of ibuprofen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN187MA2001 2001-03-02
IN187/MAS/2001 2001-03-02
IN204/MAS/2001 2001-03-07
IN204MA2001 2001-03-07

Publications (2)

Publication Number Publication Date
WO2002069936A2 WO2002069936A2 (fr) 2002-09-12
WO2002069936A3 true WO2002069936A3 (fr) 2003-02-20

Family

ID=26324890

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/000534 WO2002069936A2 (fr) 2001-03-02 2002-02-22 Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions

Country Status (2)

Country Link
AU (1) AU2002244865A1 (fr)
WO (1) WO2002069936A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107875117A (zh) * 2011-04-11 2018-04-06 维特斯集团 口服药物分散组合物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
WO2005063219A2 (fr) * 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Capsules en gelatine molle contenant de l'ibuprofene
BRPI0713054A2 (pt) * 2006-06-30 2012-04-17 Mcneil Ppc Inc cápsulas sólidas enchidas com lìquido contendo ibuprofeno
AU2007308986A1 (en) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Ibuprofen composition
WO2009069139A1 (fr) * 2007-11-28 2009-06-04 Alkem Laboratories Ltd. Forme posologique fournissant un remplissage liquide contenant de l'ibuprofène
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
CN102204882B (zh) * 2011-03-22 2013-07-24 韩彬 布洛芬的药物组合物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834966A (en) * 1986-08-01 1989-05-30 Zambon S.P.A. Pharmaceutical composition with analgesic activity
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5645856A (en) * 1994-03-16 1997-07-08 R. P. Scherer Corporation Delivery systems for hydrophobic drugs
WO1998038984A2 (fr) * 1997-03-05 1998-09-11 Sugen, Inc. Preparations d'agents pharmaceutiques hydrophobes
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834966A (en) * 1986-08-01 1989-05-30 Zambon S.P.A. Pharmaceutical composition with analgesic activity
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5645856A (en) * 1994-03-16 1997-07-08 R. P. Scherer Corporation Delivery systems for hydrophobic drugs
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
WO1998038984A2 (fr) * 1997-03-05 1998-09-11 Sugen, Inc. Preparations d'agents pharmaceutiques hydrophobes
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107875117A (zh) * 2011-04-11 2018-04-06 维特斯集团 口服药物分散组合物

Also Published As

Publication number Publication date
AU2002244865A1 (en) 2002-09-19
WO2002069936A2 (fr) 2002-09-12

Similar Documents

Publication Publication Date Title
IT1235048B (it) Derivato di 4h-benzopiran-4-one o suo sale, procedimento per produrlo e composizione farmaceutica che lo contiene come ingrediente attivo
BR0207880A (pt) Formulação farmacêutica, processo para preparação da mesma e uso de formulação sólida
IL139825A0 (en) Novel cyclosporins
IE893564L (en) Novel 3-piperidinyl-1,2-benzisoxazoles
HUP0104495A2 (hu) N-szubsztituált 2-ciano-pirrolidinek és ezeket tartalmazó gyógyászati készítmények
MXPA03011041A (es) Composiciones farmaceuticas que contienen orlistat y acidos grasos y/o sales de los mismos.
EA200300104A1 (ru) НОВАЯ γ КРИСТАЛЛИЧЕСКАЯ ФОРМА ТРЕТ-БУТИЛАМИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЕЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
AU2232288A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides
PA8559401A1 (es) Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
WO2002069936A3 (fr) Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions
BR0317567A (pt) Composição farmacêutica de liberação controlada de tamsulosina e processo para sua preparação
HK1039273A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
CA2335551A1 (fr) Analogues des hormones thyroidiennes et methodes de preparation associees
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
YU72802A (sh) Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje
CA2127374A1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent
CA2373962A1 (fr) Compositions medicinales a liberation immediate pour administration orale
DE3060423D1 (en) Dipeptides for use in the treatment of diseases, some compounds of this class, medicaments containing dipeptides and their manufacture
BR0109252A (pt) Composto, processo para produzir um composto, composição farmacêutica, e, uso de um composto ou de uma composição
CA2099585A1 (fr) Compositions pharmaceutiques
WO2001053322A3 (fr) Composes cycliques
HUP0204150A2 (hu) A cisz-lítium-4-ciano-4-[3-(ciklopentil-oxi)-4-metoxi-fenil]-ciklohexánkarboxilát monohidrátja, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmény
KR950016757A (ko) 약물중독 치료제 조성물

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP